Skip to main content
Erschienen in: Journal of Gastroenterology 4/2021

11.03.2021 | Letter to the Editor

Reply to the letter by Huo et al. regarding our manuscript “The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan”

verfasst von: Hirayuki Enomoto, Shuhei Nishiguchi

Erschienen in: Journal of Gastroenterology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Excerpt

We thank Huo et al. for their interest in our research [1]. In Japan, national measurements for anti-hepatitis viruses have been conducted with a large budget [2], and the causes of liver cirrhosis have remarkably changed over the past decade [3]. Our nationwide survey showed that a decrease in viral hepatitis-related HCC was responsible for the etiological changes in hepatocellular carcinoma (HCC)-complicated liver cirrhosis in Japan [1]. As described in the discussion section of the paper [1], our survey focused on the etiological transition, and the collected data were limited to the number of cases per institution. Therefore, we cannot provide more detailed information, such as the stages of HCC or prognosis, of our cohort. However, better control of the hepatitis virus can reduce the risk of developing liver failure and allow cirrhotic patients to receive intensive treatment, suggesting that the prognosis of HCC patients has improved in Japan. As reported from Taiwan [4] and Italy [5], data concerning changes in the HCC stage and prognosis are clinically important and useful. We plan to collect data from participating institutions and analyze them in a future study. Thank you for your valuable comments. …
Literatur
2.
Zurück zum Zitat Tanaka J, Akita T, Ko K, Miura Y, et al. Countermeasures against viral hepatitis B and C in Japan: an epidemiological point of view. Hepatol Res. 2019;49:990–1002.CrossRef Tanaka J, Akita T, Ko K, Miura Y, et al. Countermeasures against viral hepatitis B and C in Japan: an epidemiological point of view. Hepatol Res. 2019;49:990–1002.CrossRef
3.
Zurück zum Zitat Enomoto H, Ueno Y, Hiasa Y, et al. Transition in the etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2020;55:353–62.CrossRef Enomoto H, Ueno Y, Hiasa Y, et al. Transition in the etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2020;55:353–62.CrossRef
4.
Zurück zum Zitat Ho SY, Liu PH, Hsu CY, et al. Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma. Sci Rep. 2020;10:3925.CrossRef Ho SY, Liu PH, Hsu CY, et al. Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma. Sci Rep. 2020;10:3925.CrossRef
Metadaten
Titel
Reply to the letter by Huo et al. regarding our manuscript “The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan”
verfasst von
Hirayuki Enomoto
Shuhei Nishiguchi
Publikationsdatum
11.03.2021
Verlag
Springer Singapore
Erschienen in
Journal of Gastroenterology / Ausgabe 4/2021
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-021-01768-1

Weitere Artikel der Ausgabe 4/2021

Journal of Gastroenterology 4/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Krebspatienten impfen: Was? Wen? Und wann nicht?

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Nierenultraschall: Tipps vom Profi

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

„KI sieht, was wir nicht sehen“

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.